Abstract Background: pAc/Emm55 (IFx-Hu2.0) is a plasmid DNA therapy encoding a Streptococcus pyogenes-derived bacterial gene. It shows anti-tumor activity in preclinical models, but the mechanisms of anti-melanoma immunity and additive effects with immune checkpoint blockade remain unclear. Methods: B16 melanoma tumor-bearing mice were treated intratumorally with pAc/Emm55 alone and/or intraperitoneally with PD-1, CTLA-4, or LAG-3 blockade and monitored for tumor growth.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Thi
Contact Thi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack